Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02840383 · ClinicalTrials.gov registry record · NA

Trial of a Health Promoting School Approach to Positive Youth Development and Wellness Promotion

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
811
Enrollment target

NCT02840383: Completed NA study, sponsored by University of Minnesota.

NCT02840383 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 811 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02840383, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
811 participants
Enrollment target

Study Summary

Assess the effects of a school-based multi-component intervention on school connectedness, school engagement, and developmental assets through a group randomized, participatory trial.

Primary Outcome

Assess the effects of a school-based multi-component intervention on school connectedness, school engagement, and developmental assets through a group randomized, participatory trial.

Interventions

  • OTHER Intervention
  • OTHER Delayed Intervention

Trial Details

FieldValue
Enrollment Target 811 participants
Start Date 2017-09-05
Est. Completion 2022-11-20
Phase NA
University of Minnesota

966 total trials

What the finished NCT02840383 record still lists

NCT02840383 is an interventional study that assigns participants to a tested intervention. The registered 811 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower).

The record links to 0 conditions, and to 2 interventions - of which Intervention is the first listed.

NCT02840383 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02840383 about?

NCT02840383 is a clinical study titled "Trial of a Health Promoting School Approach to Positive Youth Development and Wellness Promotion". Assess the effects of a school-based multi-component intervention on school connectedness, school engagement, and developmental assets through a group randomized, participatory trial.

What is the current status of trial NCT02840383?

This trial is currently completed. It is a NA study. The enrollment target is 811 participants. The study started on 2017-09-05. Estimated completion is 2022-11-20.

What interventions are being tested in trial NCT02840383?

The interventions under investigation include: Intervention (OTHER), Delayed Intervention (OTHER).

Who is sponsoring clinical trial NCT02840383?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02840383's enrollment target sits among peer trials

811 134th of 2000 higher than 1,867 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05519085 · 810 participants · Phase 3

    A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

  • NCT06529094 · 808 participants · NA

    Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic

  • NCT07218029 · 815 participants · Phase 3

    A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

  • NCT04613596 · 806 participants · Phase 2

    Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02840383, the US trial registry maintained by the National Library of Medicine. NCT02840383 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.